Related Experiment Video
Updated: Jun 27, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Association Between Prior NRICM101 Use and Response to Incentive Spirometer Training in Patients with Long COVID
Yao-Hsiang Chen1,2, Chia-Huei Lin3,4, Ju-Han Liu1,5
1School of Nursing, National Taipei University of Nursing and Health Sciences, No. 365, Mingde Rd., Beitou Dist., Taipei City 11230, Taiwan.
Healthcare (Basel, Switzerland)
|June 26, 2026
Summary
Incentive spirometer training benefits Long COVID recovery, improving breathing and function. Prior NRICM101 use may alter rehabilitation patterns, suggesting varied recovery paths.
Area of Science:
- Respiratory Medicine
- Rehabilitation Science
- Long COVID Research
Background:
- Incentive spirometer (IS) training enhances respiratory function and quality of life in Long COVID patients.
- NRICM101 is frequently used during the acute phase of illness in Taiwan, but its long-term effects on rehabilitation are not well understood.
Purpose of the Study:
- To assess the efficacy of IS-based respiratory training for Long COVID rehabilitation.
- To investigate whether prior NRICM101 use influences the outcomes of IS training.
Main Methods:
- A six-week IS training program was implemented.
- Participants were categorized based on prior NRICM101 use and time since recovery.
- Pre- and post-training assessments measured dyspnea, functional status, six-minute walk distance, and arterial oxygen content.
Main Results:
- IS training significantly improved dyspnea, functional status, and exercise endurance in all participants.
- Early intervention (within three months of recovery) without prior NRICM101 use showed more pronounced improvements in dyspnea, functional status, and exercise endurance.
- Prior NRICM101 use was linked to distinct rehabilitation patterns.
Conclusions:
- IS training is an effective rehabilitation strategy for Long COVID.
- The influence of prior NRICM101 use on rehabilitation outcomes suggests potential differences in recovery trajectories or patient behaviors, rather than solely pharmacological effects.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...